News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canada Gives OK to Novartis Corporation (NVS) MS Pill


3/11/2011 6:30:31 AM

Pharma Times -- Novartis has bagged another approval for its multiple sclerosis pill, Gilenya, this time in Canada. Health Canada has given the green light to Gilenya (fingolimod), making it the first disease-modifying oral therapy developed for the relapsing-remitting form of MS to get approval in the country.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES